![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Dr. McCiement presents a concise review of the current drug therapy of both pulmonary and extrapulmonary manifestations of tuberculosis. The availability of new agents, such as rifampin, has significantly changed the outlook for the patient with tuberculosis. An excellent table lists 11 antituberculosis drugs with their usual dosage, toxicity, and means of patient follow-up to anticipate possible development of toxicity.-HCN